Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy

Heart

Volumn 90, Issue 10, 2004, Pages 1167-1171

  Giulia Gagliardi, M ^a   Bevilacqua, M ^a   Bassano, C ^b   Leonardi, B ^a   Boldrini, R ^a   Diomedi Camassei, F ^a   Fierabracci, A ^a   Ugazio, A G ^a   Bottazzo, G F ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ARTICLE; CHILD; COHORT ANALYSIS; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CONVALESCENCE; DOSE RESPONSE; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HIRSUTISM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; PERICARDIAL EFFUSION; PRIORITY JOURNAL; RECURRENT DISEASE; SURVIVAL RATE; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; BIOPSY; CARDIOMYOPATHY, DILATED; CHILD, PRESCHOOL; CYCLOSPORINE; ENDOCARDIUM; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; MYOCARDITIS; PREDNISONE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 4644246128     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.026641     Document Type: Article

References (28)

1. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999;99:1091-100.
2. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000;343:1388-98.
3. Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol 1987;1:3-14.
4. Taliercio CP, Seward JB, Driscoll DJ, et al. Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history. J Am Coll Cardiol 1985;6:1126-31.
5. Griffin ML, Hernandez A, Martin TC, et al. Dilated cardiomyopathy in infants and children. J Am Coll Cardiol 1988;11:139-44.
6. Chen SC, Nouri S, Balfour I, et al. Clinical profile of congestive cardiomyopathy in children. J Am Coll Cardiol 1990;15:189-93.
7. Grogan M, Redfield MM, Bailey KR, et al. Long-term outcome of patient with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1995;26:80-4.
8. Kishimoto C, Abelmann WH. In vivo significance of T cells in the development of coxsackie virus B3 myocarditis in mice: immature but antigen-specific T cells aggravate myocardial injury. Circ Res 1990;76:589-98.
9. Martino TA, Liu P, Sole MJ. Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res 1994;74:182-8.
10. Knowlton KU, Badorff C. The immune system in viral myocarditis: maintaining the balance. Circ Res 1999;85:559-61.
11. Opavsky MA, Penninger J, Aitken K, et al. Susceptibility to myocarditis is dependent on the response of T lymphocytes to coxsackieviral B3. Circ Res 1999;85:551-8.
12. Parrillo JE, Cunnion RE, Epstein SE, et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 1989;321:1061-8.
13. Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995;333:269-75.
14. Camargo PR, Snitcowsky R, da Luz PL, et al. Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatr Cardiol 1995;16:61-8.
15. Gagliardi MG, Bevilacqua M, Squitieri C, et al. Dilated cardiomyopathy caused by acute myocarditis in pediatric patients: evolution of myocardial damage in a group of potential heart transplant candidates. J Heart Lung Transplant 1993;12(suppl):S224-9.
16. Kleinert S, Weintraub RG, Wilkinson JL, et al. Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression. J Heart Lung Transplant 1997;16:1248-54.
17. Lee KJ, McCrindle BW, Bohn DJ, et al. Clinical outcome of acute myocarditis in childhood. Heart 1999;82:226-33.
18. Drucker NA, Colan SD, Lewis AB, et al. Globulin treatment of acute myocarditis in the pediatric population. Circulation 1994;89:252-7.
19. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up result. Circulation 2001;104:39-45.
20. Caforio AL, Stewart JT, Bonifacio E, et al. Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy: relevance for autoimmunity? J Autoimmun 1990;3:187-200.
21. Rein AJ, Colan SD, Parness IA, et al. Regional and global left ventricular function in infants with anomalous origin of the left coronary artery from the pulmonary trunk: preoperative and postoperative assessment. Circulation 1987;75:115-23.
22. Angelini A, Crosato M, Boffa GM, et al. Active versus borderline myocarditis: clinicopathological correlates and prognostic implications. Heart 2002;87:210-5.
23. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation 2001;104:1076-82.
24. Chow LH, Radio SJ, Sears TD, et al. Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol 1989;14:915-20.
25. Parrillo JE. Myocarditis: how should we treat in 1998? J Heart Lung Transplant 1998;17:941-4.
26. Caforio AL, Bonifacio E, Stewart JT, et al. Novel organ-specific circulating autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol 1990;15:1527-34.
27. Staudt A, Bohm M, Knebel F, et al. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 2002;106:2448-53.
28. Frustaci A, Chimenti C, Calabrese F, et al. A Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 2003;107:857-63.